Harvard Bioscience (HBIO) Amortization - Intangibles (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Amortization - Intangibles data on file, last reported at $820000.0 in Q1 2026.

• On a quarterly basis, Amortization - Intangibles fell 29.31% year-over-year to $820000.0 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 27.45% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 23.37% from the prior year.
• Amortization - Intangibles for Q1 2026 stood at $820000.0, down from $850000.0 in the prior quarter.
• Over the last five years, Amortization - Intangibles for HBIO reached as high as $1.6 million in Q4 2022 and fell as low as $820000.0 in Q1 2026.
• Historically, Amortization - Intangibles has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
• Across the five-year window, Amortization - Intangibles gained 11.11% in 2022 and sank 35.91% in 2025, its largest moves.
• Year by year, Amortization - Intangibles stood at $1.6 million in 2022, then declined by 13.31% to $1.4 million in 2023, then slipped by 9.37% to $1.3 million in 2024, then slumped by 32.38% to $850000.0 in 2025, then fell by 3.53% to $820000.0 in 2026.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $820000.0 in Q1 2026, $850000.0 in Q4 2025, and $855000.0 in Q3 2025.